TNF and rheumatoid arthritis: Thus, antinuclear (ANA) and anti-double-stranded DNA (anti-dsDNA) autoantibodies have been respectively described in up to 86% and 57% of patients with RA treated with the TNF-α blocking agent infliximab [3,7,12-16].